Adnavance Raises $3.7M in Series B Financing

Feb 26, 2008

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Adnavance Technologies said today it has taken in CDN$3.7 million (US$3.7 million) in a Series B financing.

The funding round was headed by Working Opportunity Fund, which is managed by GrowthWorks Capital, JovInvestment Management, and Business Development Bank of Canada.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu